Wegovy Maker Predicts Slower Profit Growth Amid Rising Competition
Novo Nordisk, the Danish pharmaceutical company behind Wegovy and Ozempic, has cautioned that its full-year revenue and earnings growth will likely fall short of previous expectations, citing the increasing presence…